Cartesian Growth Corporation II

RENE · NASDAQ
Analyze with AI
$11.75+$0.00 (+0%)
At close:Nov 25, 2025, 9:00 PM UTC
$11.75+$0.00 (+0%)
After hours:Nov 25, 2025, 9:00 PM UTC
P/E TTM60.86
P/B TTM-3.64
P/S TTM121
Dividend Yield0%
EPS$0.40
Beta-0.013
Valuation
PEG Ratio-1.28
FCF Yield-0.59%
EV / EBITDA-145.94
Quality
ROIC-1.27%
Gross Margin50.00%
Cash Conv. Ratio-0.65
Growth
Revenue 3Y CAGR
FCF Growth11.76%
Safety
Net Debt / EBITDA0.04
Interest Coverage0.00
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle0.00

Cartesian Growth Corporation II (RENE) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Cartesian Growth Corporation II (RENE) stock price today?

As of Nov 25, 2025, 9:00 PM UTC, Cartesian Growth Corporation II (RENE) stock is trading at $11.75. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date RENE stock quotes for informed trading decisions.

What is Cartesian Growth Corporation II's market capitalization?

Cartesian Growth Corporation II (RENE) has a market capitalization of approximately $154.5M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Cartesian Growth Corporation II's size relative to other companies in the USD market. The market cap figure updates automatically as the RENE stock price changes.

What is the 52-week range for Cartesian Growth Corporation II stock?

Cartesian Growth Corporation II (RENE) stock has traded in a 52-week range of $11.05 — $11.95. The 52-week range shows the highest and lowest prices at which RENE traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Cartesian Growth Corporation II stock price to this range provides context for recent price action.

How much trading volume does Cartesian Growth Corporation II stock have?

Cartesian Growth Corporation II (RENE) stock recently traded approximately 12.7K shares. Trading volume indicates market liquidity and investor interest in RENE. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Cartesian Growth Corporation II stock.

Does Cartesian Growth Corporation II pay dividends to shareholders?

Yes, Cartesian Growth Corporation II (RENE) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Cartesian Growth Corporation II stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Cartesian Growth Corporation II's intraday price range?

Today, Cartesian Growth Corporation II (RENE) stock has traded in a range of $11.75 — $11.75. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring RENE's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Cartesian Growth Corporation II stock data?

AlphaPilot sources real-time RENE stock quotes, fundamental financial data, and historical price charts for Cartesian Growth Corporation II from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Cartesian Growth Corporation II stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of RENE stock performance.